How many institutions held AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share in Q4 2019?

6 institutional investors reported AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share for Q4 2019. Use the holders table for investor-level position and value details.

AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI)

Q: What does CUSIP 00901B105 represent in this 13F holders report?

CUSIP 00901B105 is the security identifier for AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 00901B105

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 67,129,058
Total 13F shares: 564,017
Share change: -707,936
Total reported value: $307,124
Price per share: $0.54
Number of holders: 6
Value change: -$619,201
Number of buys: 3
Number of sells: 5

Quarterly Holders Quick Answers

What is CUSIP 00901B105?
CUSIP 00901B105 identifies AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2020
Previous quarter: Q3 2019

Recent filing periods for CUSIP 00901B105:

Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023

Top shareholders of AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Anson Funds Management LP	13F	Company	0.77%	515,124	$393,000	—	30 Sep 2019	13F
Hudson Bay Capital Management LP	13F	Company	0.59%	394,900	$301,000	—	30 Sep 2019	13F
SABBY MANAGEMENT, LLC	13F	Company	0.28%	185,171	$141,000	—	30 Sep 2019	13F
MORGAN STANLEY	13F	Company	0.21%	143,820	$110,000	—	30 Sep 2019	13F
A.R.T. Advisors, LLC	13F	Company	0.02%	12,369	$9,000	—	30 Sep 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	10,230	$8,000	—	30 Sep 2019	13F
BlackRock Finance, Inc.	13F	Company	0.02%	10,111	$8,000	—	30 Sep 2019	13F
American Portfolios Advisors	13F	Company	0%	228	$174	—	30 Sep 2019	13F

Institutional Holders of AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) as of Q4 2019

As of 31 Dec 2019, AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 564,017 shares. The largest 6 holders included SABBY MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., DEUTSCHE BANK AG\, BANK OF AMERICA CORP /DE/, and American Portfolios Advisors. This page lists 6 institutional shareholders reporting positions in this security for the Q4 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders

Q4 2019 holders

Holder diff

-2

Investor	Q3 2019 Shares	Q4 2019 Shares	Share Diff	Share Chg %	Q3 2019 Value $	Q4 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.